[Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
Nagata
Towako
T
Mukae
Hiroshi
H
Kadokawa
Tomoyuki
T
Kaida
Hideyuki
H
Kuroki
Misuzu
M
Yanagihara
Katsunori
K
Asano
Kazunori
K
Kadota
Jyunichi
J
Koji
Takehiko
T
Kawano
Shigeru
S
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D018441:Biofilms / Q000254:growth & development*; D002908:Chronic Disease; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004917:Erythromycin / Q000008:administration & dosage* / Q000494:pharmacology; D008168:Lung / Q000382:microbiology; D051379:Mice; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D004917:Erythromycin